Grail (GRAL) Non-Current Deferred Tax Liability (2023 - 2026)
Grail's (GRAL) quarterly Non-Current Deferred Tax Liability came in at $184.0 million in Q1 2026, down 39.7% YoY from $305.2 million in Q1 2025, and down 15.81% on a QoQ basis from $218.6 million in Q4 2025.
Grail (GRAL) Non-Current Deferred Tax Liability (2023 - 2026) Analysis & Trends
Grail (GRAL) has 4 years of Non-Current Deferred Tax Liability data on file, last reported at $184.0 million in Q1 2026.
- Quarterly Non-Current Deferred Tax Liability fell 39.7% year-over-year to $184.0 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $184.0 million (down 39.7% YoY) and the FY2025 annual result came in at $218.6 million, down 36.8% from the prior year.
- Non-Current Deferred Tax Liability declined to $184.0 million in Q1 2026, from $218.6 million in the prior quarter.
- In the past five years, Non-Current Deferred Tax Liability ranged from a high of $676.0 million in Q4 2023 to a low of $184.0 million in Q1 2026.
- A 4-year average of $336.6 million and a median of $305.2 million in 2025 frame the typical range for Non-Current Deferred Tax Liability.
- Annual changes were most pronounced in 2024 — Non-Current Deferred Tax Liability plunged 48.84% — and 2025, when it plunged 36.8%.
- Tracing GRAL's Non-Current Deferred Tax Liability over 4 years: stood at $676.0 million in 2023, then sank by 48.84% to $345.9 million in 2024, then sank by 36.8% to $218.6 million in 2025, then retreated by 15.81% to $184.0 million in 2026.
- The last three Non-Current Deferred Tax Liability figures came in at $184.0 million (Q1 2026), $218.6 million (Q4 2025), and $236.3 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Thermo Fisher Scientific | 234.15 Bn | 230.09 Bn | 8.34 Bn |
| 2 | Danaher | 152.10 Bn | 147.75 Bn | 3.61 Bn |
| 3 | Natera | 48.48 Bn | 47.38 Bn | 486.15 Mn |
| 4 | Agilent Technologies | 44.35 Bn | 42.55 Bn | 990.00 Mn |
| 5 | Iqvia Holdings | 43.68 Bn | 41.60 Bn | 1.44 Bn |
| 6 | Idexx Laboratories | 43.02 Bn | 42.83 Bn | 779.09 Mn |
| 7 | Illumina | 34.39 Bn | 33.22 Bn | 770.00 Mn |
| 8 | Mettler Toledo International | 28.29 Bn | 28.24 Bn | 650.22 Mn |
| 9 | Labcorp Holdings | 27.51 Bn | 27.37 Bn | 1.11 Bn |
| 10 | Grail | 3.56 Bn | 2.70 Bn | 21.34 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 133.71 Mn |
| Jun 30, 2026 | 133.71 Mn |
| Mar 31, 2026 | 184.04 Mn |
| Mar 31, 2026 | 184.04 Mn |
| Dec 31, 2025 | 218.58 Mn |
| Dec 31, 2025 | 218.58 Mn |
| Sep 30, 2025 | 236.27 Mn |
| Sep 30, 2025 | 236.27 Mn |
| Jun 30, 2025 | 266.17 Mn |
| Jun 30, 2025 | 266.17 Mn |
| Mar 31, 2025 | 305.19 Mn |
| Mar 31, 2025 | 305.19 Mn |
| Dec 31, 2024 | 504.95 Mn |
| Dec 31, 2024 | 504.95 Mn |
| Sep 30, 2024 | 375.12 Mn |
| Sep 30, 2024 | 375.12 Mn |
| Jun 30, 2024 | 422.16 Mn |
| Jun 30, 2024 | 422.16 Mn |
| Dec 31, 2023 | 676.03 Mn |
| Dec 31, 2023 | 676.03 Mn |